Pantoprazole Levosulpiride

PANTAVIB L

null
COMPOSITION
Pantoprazole40MG
Levosulpiride75MG
SPECIFICATION
FORMCAPSULE
PACKING 10×10
PACKING TYPEALU ALU
MRP1490

DESCRIPTION

Pantoprazole is a proton pump inhibitor drug used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.

SIDE EFFECTS

Short-term (up to 16 weeks) treatment of erosive esophagitis.

INDICATION

Single intravenous doses of pantoprazole at 378, 230, and 266 mg/kg (38, 46, and 177 times the recommended human dose based on body surface area) were lethal to mice, rats and dogs, respectively. The symptoms of toxicity included hypoactivity, ataxia, hunched sitting, limb-splay, lateral position, segregation, absence of ear reflex, and tremor. There is limited experience regarding cases of human overdosage, and treatment should be symptomatic and supportive.

Important Notice:-  The Database is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

null